Revolution Medicines Inc Warrant
RVMDW
22 hedge funds and large institutions have $2.46M invested in Revolution Medicines Inc Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
12% more capital invested
Capital invested by funds: $2.2M → $2.46M (+$254K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.1% less ownership
Funds ownership: 73.17% → 73.07% (-0.1%)
4% less funds holding
Funds holding: 23 → 22 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$28.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$28.8K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$3.98K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$816 |
RVMDW Hedge Fund Activity: Q3 2025 in Review
22 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q3 2025, worth a combined $2.46M — up 12% from $2.2M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RVMDW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Aristeia Capital, adding an estimated $28.6K. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $28.8K sold.
- 22 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q3 2025, down from 23 in Q2 2025.
- Funds reported $2.46M of Revolution Medicines Inc Warrant stock for Q3 2025, up 12% quarter-over-quarter.
- 0 funds opened new Revolution Medicines Inc Warrant positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest Revolution Medicines Inc Warrant buyer in Q3 2025 was Aristeia Capital, an estimated $28.6K added.
- The largest Revolution Medicines Inc Warrant seller in Q3 2025 was Cantor Fitzgerald, an estimated $28.8K sold.
Based on aggregated 13F filings for Q3 2025.